Biogen reports fourth case of rare disease in patient who took MS drug

BOSTON (AP) - The maker of a multiple sclerosis drug that has been pulled from the market said a fourth patient may have contracted a potentially fatal disease after being treated with the drug, the Boston Globe reported Thursday. Biogen Idec Inc. told the U.S....More